IOL CHEMICALS & PHARM. | VENUS REMEDIES | IOL CHEMICALS & PHARM./ VENUS REMEDIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.1 | 15.3 | 85.8% | View Chart |
P/BV | x | 1.5 | 1.0 | 154.8% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. VENUS REMEDIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
VENUS REMEDIES Mar-23 |
IOL CHEMICALS & PHARM./ VENUS REMEDIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 379 | 141.6% | |
Low | Rs | 272 | 145 | 187.7% | |
Sales per share (Unadj.) | Rs | 377.6 | 415.5 | 90.9% | |
Earnings per share (Unadj.) | Rs | 23.7 | 19.9 | 119.3% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 44.0 | 71.7% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 344.3 | 74.6% | |
Shares outstanding (eoy) | m | 58.71 | 13.37 | 439.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.6 | 169.9% | |
Avg P/E ratio | x | 17.1 | 13.2 | 129.5% | |
P/CF ratio (eoy) | x | 12.8 | 5.9 | 215.4% | |
Price / Book Value ratio | x | 1.6 | 0.8 | 207.0% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 3,501 | 678.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 570 | 294.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 5,555 | 399.1% | |
Other income | Rs m | 256 | 103 | 248.1% | |
Total revenues | Rs m | 22,427 | 5,658 | 396.4% | |
Gross profit | Rs m | 2,257 | 602 | 374.9% | |
Depreciation | Rs m | 462 | 323 | 142.9% | |
Interest | Rs m | 165 | 3 | 5,602.0% | |
Profit before tax | Rs m | 1,887 | 379 | 497.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 114 | 435.6% | |
Profit after tax | Rs m | 1,391 | 266 | 523.8% | |
Gross profit margin | % | 10.2 | 10.8 | 93.9% | |
Effective tax rate | % | 26.2 | 30.0 | 87.6% | |
Net profit margin | % | 6.3 | 4.8 | 131.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 3,230 | 299.3% | |
Current liabilities | Rs m | 5,025 | 826 | 608.6% | |
Net working cap to sales | % | 20.9 | 43.3 | 48.4% | |
Current ratio | x | 1.9 | 3.9 | 49.2% | |
Inventory Days | Days | 43 | 37 | 117.2% | |
Debtors Days | Days | 8 | 504 | 1.7% | |
Net fixed assets | Rs m | 11,017 | 2,781 | 396.1% | |
Share capital | Rs m | 587 | 134 | 439.2% | |
"Free" reserves | Rs m | 14,490 | 4,470 | 324.2% | |
Net worth | Rs m | 15,077 | 4,603 | 327.5% | |
Long term debt | Rs m | 0 | 387 | 0.0% | |
Total assets | Rs m | 20,684 | 6,011 | 344.1% | |
Interest coverage | x | 12.5 | 130.0 | 9.6% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.9 | 116.0% | |
Return on assets | % | 7.5 | 4.5 | 168.4% | |
Return on equity | % | 9.2 | 5.8 | 159.9% | |
Return on capital | % | 13.6 | 7.7 | 177.6% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 366 | 333.8% | |
From Investments | Rs m | -1,200 | -508 | 236.1% | |
From Financial Activity | Rs m | -41 | -6 | 723.6% | |
Net Cashflow | Rs m | -18 | -220 | 8.3% |
Indian Promoters | % | 48.2 | 41.8 | 115.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 1.5 | 114.9% | |
FIIs | % | 1.4 | 1.5 | 94.6% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 58.2 | 89.0% | |
Shareholders | 130,003 | 19,913 | 652.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | VENUS REMEDIES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.57% | -0.87% | -0.65% |
1-Month | -4.88% | 2.55% | 1.94% |
1-Year | -4.46% | 58.00% | 49.50% |
3-Year CAGR | -12.12% | 2.89% | 14.13% |
5-Year CAGR | 15.26% | 59.20% | 19.14% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the VENUS REMEDIES share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of VENUS REMEDIES the stake stands at 41.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of VENUS REMEDIES.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
VENUS REMEDIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of VENUS REMEDIES.
For a sector overview, read our pharmaceuticals sector report.
It was indeed a volatile trading session for Indian share markets yesterday.